• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Vascular Closure

Press Release: Transluminal Technologies receives CE Mark approval for velox CD vascular closure device

August 4, 2014 By MassDevice Contributors Network Leave a Comment

Press Release: Transluminal Technologies receives CE Mark approval for velox CD vascular closure device

Filed Under: Regulatory/Compliance, Vascular Tagged With: CE Mark, Press Release, Transluminal Technologies, Vascular Closure

Transluminal Tech lands E.U. win for bioabsorbable vascular closure

August 4, 2014 By Arezu Sarvestani Leave a Comment

Transluminal Tech lands E.U. win for bioabsorbable vascular closure

Transluminal Technologies is ready to take on the European market with CE Mark approval for its flagship Velox CD vascular closure devices.

Filed Under: News Well, Regulatory/Compliance, Vascular Tagged With: CE Mark, Transluminal Technologies, Vascular Closure

EndoShape raises $6.8M for vascular plugs and coils

June 20, 2014 By Arezu Sarvestani Leave a Comment

EndoShape raises $6.8M for vascular plugs and coils

EndoShape is in the process of raising $6.8 million in the latest reported funding round for the minimally invasive vessel occlusion devices maker.

Filed Under: Funding Roundup, News Well Tagged With: Coil Embolization, EndoShape Inc., Endovascular, Vascular Closure

Cardinal Health closes $320M AccessClosure buy

May 12, 2014 By Brad Perriello Leave a Comment

Cardinal Health closes $320M AccessClosure buy

Cardinal Health (NYSE:CAH) said today that it closed its $320 million all-cash acquisition of AccessClosure and its Mynx extravascular closure technology.

The Mynx biodegradable sealant products are designed to close off the femoral artery and then dissolve within 30 days.

Filed Under: Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Access Closure Inc., Cardinal Health, Vascular Closure

Admedus gains U.S. clearance for cardiovascular scaffold

February 19, 2014 By Chris Walker Leave a Comment

Admedus gains U.S. clearance for cardiovascular scaffold

Admedus won 510(k) clearance from the U.S. FDA for its CardioCel cardiovascular scaffold.

Perth, Australia and Minneapolis, Minn.-based Admedus is developing implantable regenerative technologies. CardioCel, the company’s 1st product, is a pure collagen, bio-compatible regenerative tissue scaffold.

Filed Under: Cardiovascular, Food & Drug Administration (FDA), News Well, Regulatory/Compliance, Vascular Tagged With: Admedus Ltd., Minnesota, Vascular Closure

Sapheon wins Canadian approval for medical adhesive

January 31, 2014 By Chris Walker Leave a Comment

Sapheon wins Canadian approval for medical adhesive

Sapheon secured approval from Health Canada for its VenaSeal Sapheon closure system, used in the treatment of varicose veins.

Morrisville, N.C.-based Sapheon develops treatments for vascular disease, its flagship product being the VenaSeal, a medical adhesive which seals blood vessels using a special glue. The company is currently working towards getting pre-market approval from the U.S. FDA.

Filed Under: News Well, Regulatory/Compliance, Vascular Tagged With: Exports, Health Canada, Sapheon Inc, Vascular Closure

Federal court rejects St. Jude’s appeal in infringement case against AccessClosure

December 11, 2013 By Arezu Sarvestani Leave a Comment

Federal court rejects St. Jude's appeal in infringement case against AccessClosure

Medtech titan St. Jude Medical’s (NYSE:STJ) lost a bid to appeal its lawsuit against AccessClosure after a federal court refused to hear a patent infringement claim over artery closure devices.

Filed Under: Legal News, News Well, Patent Infringement Tagged With: AccessClosure, Minnesota, stjudemedical, Vascular Closure

Scion Biomedical sues board member for trade secret theft

November 26, 2013 By Brad Perriello Leave a Comment

Scion Biomedical sues board member for trade secret theft

Scion Biomedical sued board member and interim chief strategy and operating officer Allison London Brown, accusing her of poaching trade secrets for her startup medical device company, Aegis Women’s Health Technologies.

Filed Under: Legal News, News Well, Women's Health Tagged With: Aegis Women's Health Technologies, Scion Biomedical, Vascular Closure

Vascular Solutions settles Terumo patent infringement beef for $812k

October 23, 2013 By Brad Perriello Leave a Comment

Vascular Solutions settles Terumo patent infringement beef for $812k
Vascular Solutions settles Terumo patent infringement beef for $812k

Filed Under: Legal News, News Well, Patent Infringement Tagged With: Terumo, Vascular Closure, vascularsolutions

Appeals court reverses St. Jude Medical win over Access Closure

September 12, 2013 By Brad Perriello Leave a Comment

St. Jude Medical logo
Access Closure logo

Filed Under: Legal News, News Well, Patent Infringement Tagged With: Access Closure Inc., Minnesota, stjudemedical, Vascular Closure

FDA OKs Cardiva Medical’s Vascade vascular closure system

February 7, 2013 By MassDevice staff Leave a Comment

Cardiva Medical logo

California medical device company Cardiva Medical won FDA approval for its Vascade extravascular closure device, the company announced this week.

The premarket approval was granted based on evidence from Cardiva’s 420-patient clinical trial, which demonstrated that Vascade beat the gold standard of manual compression for vascular closure patients undergoing percutaneous procedures via the femoral artery, according to a press release.

Filed Under: Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Cardiva Medical Inc., Vascular Closure

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy